Abdi İbrahim, which has led the Turkish pharmaceutical sector for 24 consecutive years, has certified its equal pay policies through an independent international body. The company received the Equal Pay certification from the Switzerland-based EQUAL-SALARY Foundation, making it the first pharmaceutical enterprise in Turkey to hold the accreditation.
During the audit process, the company's compensation and benefits data were evaluated by an independent auditing firm to confirm compliance with global criteria. The accreditation directly supports Abdi İbrahim's HEAL2050 sustainability framework, addressing Sustainable Development Goals including Gender Equality (SDG 5), Decent Work and Economic Growth (SDG 8), and Reduced Inequalities (SDG 10).
Executive Statement
Commenting on the certification and the company's workplace equality standards, Süha Taşpolatoğlu, CEO of Abdi İbrahim, stated:
We are proud to be among the pioneering organizations in the Turkish business world to receive the Equal Pay certification awarded by the EQUAL-SALARY Foundation, and to be the first company in the Turkish pharmaceutical sector to hold this certification. At Abdi İbrahim, aware of the responsibility that comes with being one of our country's largest employers, we adopt a fair and egalitarian working approach as a core element of our corporate culture. Founded 114 years ago and achieving sustainable success through the joint contributions of male and female employees for over a century, we view the independent validation of our inclusive working model as a major source of motivation for our future endeavors.
